TALIS BIOMEDICAL CORP - COM (TLIS)

CUSIP: 87424L108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
16,744,609
Share change
-755,463
Total reported value
$23,617,000
Price per share
$1.41
Number of holders
40
Value change
-$1,333,831
Number of buys
14
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q1 2022

As of 31 Mar 2022, TALIS BIOMEDICAL CORP - COM (TLIS) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,744,609 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, GREENLIGHT CAPITAL INC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, PRELUDE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, and Parametric Portfolio Associates LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.